MKI67 and neoplasm: By applying the Ki67 Working Group recommendation that only Ki67 scores ≤ 5% or ≥ 30% should be used for subtyping, then depending on the scoring method applied, up to 78.1% of tumours would remain unclassified because of their middle‐range Ki67 scores [7].